search
Back to results

The Penn Lifestyle Modification and Blood Pressure Study

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Iyengar yoga
Enhanced nutritional care classes
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Subjects must be willing to, and have the capacity for, giving written informed consent. Between the ages of 18 and 70 Blood pressure (BP) criteria: systolic blood pressure (SBP) of > 130 but < 160 mm Hg and diastolic blood pressure (DBP) < 100 mmHg All subjects must be willing to comply with all study-related procedures. Exclusion Criteria: Female subjects who are pregnant or post partum < 3 months Subjects currently taking blood pressure lowering medications or dietary supplements (magnesium, potassium, calcium > 1200 mg/day, fish oils > 2000 mg/day, ephedra, hawthorn, forskolin) Non-dominant arm circumference > 50 cm Subjects with body mass index (BMI) >= 40.0 or < 18.5 kg/m2 Subjects who have practiced IY in the last 12 months or those who have practiced any form of yoga > 2 times (2x)/month in the previous 6 months. Subjects who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of greater than or equal to one pint within 8 weeks prior to screening. Subjects with diabetes mellitus Subjects with established cardiovascular disease Subjects with known arrhythmias such as atrial flutter or fibrillation or those with cardiac pacemakers Current users (within the previous 30 days) of any tobacco products History of renal insufficiency based on estimated glomerular filtration rate < 60 ml/min Women who consume > 10 alcoholic drinks per week and men who consume > 15 drinks per week. Subjects with known autonomic neuropathy (e.g: Shy-Drager, orthostatic hypotension) Subjects with known secondary causes of hypertension (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronemia) Regular use of benzodiazepines, anti-psychotic drugs or corticosteroids (> 1x per month). Stable doses (3 months) of antidepressants (selective serotonin reuptake inhibitors [SSRIs] or tricyclic antidepressants [TCAs]) will be allowed. Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga Subjects who actively practice (> 2x/month) other mind-body therapy (MBT) such as Qigong, Tai Chi, or meditation.

Sites / Locations

  • University of Pennsylvania

Outcomes

Primary Outcome Measures

systolic blood pressure

Secondary Outcome Measures

heart rate variability
lipids
safety markers
quality of life measures
physiologic markers of stress
insulin resistance
pulse wave velocity

Full Information

First Posted
May 18, 2006
Last Updated
November 24, 2015
Sponsor
University of Pennsylvania
Collaborators
National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT00328666
Brief Title
The Penn Lifestyle Modification and Blood Pressure Study
Official Title
Cardiovascular Effects of Iyengar Yoga vs. Enhanced Usual Care in Patients With High-normal to Stage I Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
November 2015
Overall Recruitment Status
Completed
Study Start Date
February 2005 (undefined)
Primary Completion Date
January 2007 (Actual)
Study Completion Date
January 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania
Collaborators
National Institutes of Health (NIH)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to compare the effects of 12 weeks of structured classes of either iyengar yoga (IY) or an enhanced usual care intervention on blood pressure, heart rate variability, quality of life measures, lipid measures, and safety in patients with high-normal to stage I hypertension.
Detailed Description
This is a single site, parallel, non-blinded, randomized controlled trial to assess the safety and efficacy of 12 weeks of structured IY vs. enhanced usual care in adults with high-normal to stage I HTN. All potential subjects will be screened first by telephone and then by an outpatient visit at the General Clinical Research Center (GCRC) at either the hospital of the University of Pennsylvania (HUP) or the Presbyterian Medical Center (PMC). Eligible subjects will then make 4 visits to the GCRC where, during 3 visits, they will be admitted overnight to have non-invasive 24 hour recordings of blood pressure and heart rate variability as well as periodic blood and urine collections. In order to assess durability of biologic effects once the formal intervention is stopped, we added a 4 week follow up visit. The entire study duration is 18 weeks (16 weeks post-randomization) and includes a total of 5 visits. Subjects will be randomized to either the IYP or Blood Pressure Education Program (BPEP) which will be incorporated into off-site, small group classes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Iyengar yoga
Intervention Type
Behavioral
Intervention Name(s)
Enhanced nutritional care classes
Primary Outcome Measure Information:
Title
systolic blood pressure
Secondary Outcome Measure Information:
Title
heart rate variability
Title
lipids
Title
safety markers
Title
quality of life measures
Title
physiologic markers of stress
Title
insulin resistance
Title
pulse wave velocity

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects must be willing to, and have the capacity for, giving written informed consent. Between the ages of 18 and 70 Blood pressure (BP) criteria: systolic blood pressure (SBP) of > 130 but < 160 mm Hg and diastolic blood pressure (DBP) < 100 mmHg All subjects must be willing to comply with all study-related procedures. Exclusion Criteria: Female subjects who are pregnant or post partum < 3 months Subjects currently taking blood pressure lowering medications or dietary supplements (magnesium, potassium, calcium > 1200 mg/day, fish oils > 2000 mg/day, ephedra, hawthorn, forskolin) Non-dominant arm circumference > 50 cm Subjects with body mass index (BMI) >= 40.0 or < 18.5 kg/m2 Subjects who have practiced IY in the last 12 months or those who have practiced any form of yoga > 2 times (2x)/month in the previous 6 months. Subjects who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of greater than or equal to one pint within 8 weeks prior to screening. Subjects with diabetes mellitus Subjects with established cardiovascular disease Subjects with known arrhythmias such as atrial flutter or fibrillation or those with cardiac pacemakers Current users (within the previous 30 days) of any tobacco products History of renal insufficiency based on estimated glomerular filtration rate < 60 ml/min Women who consume > 10 alcoholic drinks per week and men who consume > 15 drinks per week. Subjects with known autonomic neuropathy (e.g: Shy-Drager, orthostatic hypotension) Subjects with known secondary causes of hypertension (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronemia) Regular use of benzodiazepines, anti-psychotic drugs or corticosteroids (> 1x per month). Stable doses (3 months) of antidepressants (selective serotonin reuptake inhibitors [SSRIs] or tricyclic antidepressants [TCAs]) will be allowed. Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga Subjects who actively practice (> 2x/month) other mind-body therapy (MBT) such as Qigong, Tai Chi, or meditation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raymond Townsend, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Penn Lifestyle Modification and Blood Pressure Study

We'll reach out to this number within 24 hrs